Epicore BioNetworks Inc. Announces Corporate Actions

    CALGARY, Feb. 3 /CNW/ - Epicore BioNetworks Inc. announces the retirement
of Jean C. Messier as a director of the corporation. Mr. Messier has served
the Board faithfully and diligently for nine years and his support and
guidance helped Epicore evolve from a struggling startup to a successful
enterprise. With his extensive sales and marketing expertise, Mr. Messier made
numerous contributions to Epicore's business plans throughout the years. The
Board wishes him the best in his retirement years.
    Additionally, Epicore BioNetworks Inc. announces it has granted stock
options to directors, pursuant to the Company's director compensation plan, to
an officer and to employees of the company. The number of options granted is
350,000, which is equivalent to 1.5% of Epicore's issued common stock. Under
the terms of the Epicore Stock Option Plan, options may be issued from time to
time in any amount up to a maximum of 4,704,247 Epicore common shares. These
options have an exercise price of Cdn $0.10 and expire in five years. Included
in the grant are 100,000 share options to the Chief Financial Officer.

    Epicore BioNetworks Inc. is a leading producer of environmental
biotechnology and animal nutrition products. It manufactures in the USA and
markets worldwide to a variety of industries to reduce environmental pollution
and increase operational productivity.
    Epicore BioNetworks Inc. is a public corporation with a registered office
in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange
(symbol EBN). (The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of this release.)

    This press release contains forward-looking statements that involve
significant risks and uncertainties. The actual results, performance or
achievements of the Company might differ materially from the results,
performance or achievements of the Company expressed or implied by such
forward-looking statements. Such forward-looking statements include, without
limitation, those regarding the development plans of the Company and the
expected timing and results of such development. We can provide no assurance
that such development will proceed as currently anticipated or that the
expected timing or results of such development will be realized. We are
subject to various risks, including the uncertainties of product development,
markets for our products and regulatory review, our need for additional
capital to fund our operations, our reliance on collaborative partners, our
history of losses, and other risks inherent in the biotechnology industry.

For further information:

For further information: Mr. William P. Long, (Chief Executive Officer),
Tel: (609) 267-9118

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890